Anthony DiTonno compensation by year
TENAX THERAPEUTICS Summary Compensation Table · all 4 fiscal years held| Component | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
| Salary | $278,333 | $430,000 | $440,750 | $262,056 |
| Bonus | $0 | $0 | $0 | $0 |
| Stock awards | $0 | $0 | $0 | $0 |
| Option awards | $256,556 | $0 | $71,709 | $215,455 |
| Non-equity incentive | $80,625 | $75,250 | $221,450 | $119,952 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 |
| All other | $30,252 | $0 | $0 | $462,108 |
| Total | $645,766 | $505,250 | $733,909 | $1,059,571 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TENAX THERAPEUTICS, INC. DEF 14A filed April 28, 2022, accession 0001654954-22-005509, and prior-year filings.
How this page was built: the TENAX THERAPEUTICS, INC. filed document, accession 0001654954-22-005509. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2022.
TENAX THERAPEUTICS’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Anthony DiTonno · this page | Former Chief Executive Officer | $1,059,571 |
| Michael Jebsen | Former President and Chief Financial Officer | $980,375 |
| Christopher Giordano | President and Chief Executive Officer | $860,913 |
| Stuart Rich | Chief Medical Officer | $818,315 |
| Eliot Lurier | Interim Chief Financial Officer | $25,900 |
The full TENAX THERAPEUTICS compensation record
free company briefThis page is one person within TENAX THERAPEUTICS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TENAX THERAPEUTICS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.